chrX-110694190-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001143981.2(CHRDL1):āc.751A>Gā(p.Ile251Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,208,346 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001143981.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRDL1 | NM_001143981.2 | c.751A>G | p.Ile251Val | missense_variant | 8/12 | ENST00000372042.6 | NP_001137453.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRDL1 | ENST00000372042.6 | c.751A>G | p.Ile251Val | missense_variant | 8/12 | 2 | NM_001143981.2 | ENSP00000361112 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111885Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34039
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182674Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67154
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1096408Hom.: 0 Cov.: 28 AF XY: 0.0000111 AC XY: 4AN XY: 361816
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111938Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34102
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CHRDL1-related conditions. This variant is present in population databases (rs781026512, gnomAD 0.008%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 251 of the CHRDL1 protein (p.Ile251Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at